Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abbas F Almulla

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Current Topics in Medicinal Chemistry|January 30, 2020
Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit SchizophreniaHussein K Al-Hakeim, Abbas F Almulla, Arafat H Al-Dujaili, et al.
Journal of Advanced Research|November 15, 2023
T helper-1 activation via interleukin-16 is a key phenomenon in the acute phase of severe, first-episode major depressive disorder and suicidal behaviorsAbbas F Almulla, Ali Abbas Abo Algon, Chavit Tunvirachaisakul, et al.
Cells|November 26, 2022
Increased Lipid Peroxidation and Lowered Antioxidant Defenses Predict Methamphetamine Induced PsychosisHussein Kadhem Al-Hakeim, Mazin Fadhil Altufaili, Abbas F Almulla, et al.
Neuro Endocrinology Letters|May 4, 2025
Chronic fatigue syndrome, depression, and anxiety symptoms due to relapsing-remitting multiple sclerosis are associated with reactivation of Epstein-Barr virus and Human Herpesvirus 6Michael Maes, Abbas F Almulla, Elroy Vojdani, et al.
Schizophrenia Research|May 30, 2020
Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathwaysAbbas F Almulla, Hussein Kadhem Al-Hakeim, Mokhlad Swadi Abed, et al.
Journal of Affective Disorders|June 30, 2024
T cell activation and lowered T regulatory cell numbers are key processes in severe major depressive disorder: Effects of recurrence of illness and adverse childhood experiencesMichael Maes, Bo Zhou, Muanpetch Rachayon, et al.
Asian Journal of Psychiatry|August 11, 2023
Anxiety due to Long COVID is partially driven by activation of the tryptophan catabolite (TRYCAT) pathwayHussein Kadhem Al-Hakeim, Anwar Khairi Abed, Abbas F Almulla, et al.
BMC Psychiatry|May 7, 2026
Lower insulin resistance in Chinese patients with severe major depressive disorder: associations with the inflammatory responseYueyang Luo, Mengqi Niu, Tangcong Chen, et al.
Frontiers in Molecular Neuroscience|June 19, 2023
Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVIDHussein Kadhem Al-Hakeim, Anwar Khairi Abed, Shatha Rouf Moustafa, et al.
Brain Sciences|May 27, 2023
The Cytokine, Chemokine, and Growth Factor Network of Prenatal DepressionMichael Maes, Yoshiko Abe, Wandee Sirichokchatchawan, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Current Topics in Medicinal Chemistry|January 30, 2020
Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit SchizophreniaHussein K Al-Hakeim, Abbas F Almulla, Arafat H Al-Dujaili, et al.
Journal of Advanced Research|November 15, 2023
T helper-1 activation via interleukin-16 is a key phenomenon in the acute phase of severe, first-episode major depressive disorder and suicidal behaviorsAbbas F Almulla, Ali Abbas Abo Algon, Chavit Tunvirachaisakul, et al.
Cells|November 26, 2022
Increased Lipid Peroxidation and Lowered Antioxidant Defenses Predict Methamphetamine Induced PsychosisHussein Kadhem Al-Hakeim, Mazin Fadhil Altufaili, Abbas F Almulla, et al.
Neuro Endocrinology Letters|May 4, 2025
Chronic fatigue syndrome, depression, and anxiety symptoms due to relapsing-remitting multiple sclerosis are associated with reactivation of Epstein-Barr virus and Human Herpesvirus 6Michael Maes, Abbas F Almulla, Elroy Vojdani, et al.
Schizophrenia Research|May 30, 2020
Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathwaysAbbas F Almulla, Hussein Kadhem Al-Hakeim, Mokhlad Swadi Abed, et al.
Journal of Affective Disorders|June 30, 2024
T cell activation and lowered T regulatory cell numbers are key processes in severe major depressive disorder: Effects of recurrence of illness and adverse childhood experiencesMichael Maes, Bo Zhou, Muanpetch Rachayon, et al.
Asian Journal of Psychiatry|August 11, 2023
Anxiety due to Long COVID is partially driven by activation of the tryptophan catabolite (TRYCAT) pathwayHussein Kadhem Al-Hakeim, Anwar Khairi Abed, Abbas F Almulla, et al.
BMC Psychiatry|May 7, 2026
Lower insulin resistance in Chinese patients with severe major depressive disorder: associations with the inflammatory responseYueyang Luo, Mengqi Niu, Tangcong Chen, et al.
Frontiers in Molecular Neuroscience|June 19, 2023
Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVIDHussein Kadhem Al-Hakeim, Anwar Khairi Abed, Shatha Rouf Moustafa, et al.
Brain Sciences|May 27, 2023
The Cytokine, Chemokine, and Growth Factor Network of Prenatal DepressionMichael Maes, Yoshiko Abe, Wandee Sirichokchatchawan, et al.
Pageof 9